EUVIMEDEUVIMED entdecken
Fallbericht

Pathological complete response with FOLFIRINOX therapy for recurrence of pancreatic acinar cell carcinoma

Katsuhito Teramatsu, Nao Fujimori, Masatoshi Murakami, Sho Yasumori, Kazuhide Matsumoto, Kohei Nakata, Masafumi Nakamura, Yutaka Koga, Yoshinao Oda, Yoshihiro Ogawa

Clinical Journal of Gastroenterology · 2024

DOI: 10.1007/s12328-024-01983-2 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Clinical Journal of Gastroenterology, 2024. Verfasst von Katsuhito Teramatsu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, 3-1-1, Maidashi, Higashi-ku, Fukuoka, 812-8…. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Irinotecan, Antineoplastic Combined Chemotherapy Protocols, Oxaliplatin. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 27 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pancreatic acinar cell carcinoma (PACC) is a very rare subtype of pancreatic cancer. Due to small number of patients, no standard chemotherapy protocol has been established. We experienced an extremely rare case of PACC with liver metastasis that showed a pathological complete response after modified FOLFIRINOX (mFFX) therapy. A 42-year-old man who underwent distal pancreatectomy for an 80 mm tumor at the pancreatic tail 3 years ago was referred to our hospital in September 2017 for the treatment of a recurrent liver tumor. Percutaneous biopsy revealed an acinar-neuroendocrine carcinoma, similar to the surgical specimen. He received eight cycles of irinotecan plus cisplatin chemotherapy. However, the tumor increased in size, and treatment was switched to mFFX therapy. The tumor in the liver shrank remarkably after nine cycles of mFFX therapy. Conversion surgery was selected, and the patient underwent hepatic left and caudate lobectomy 8 months after administration of mFFX. The resected specimen showed no viable tumor cells, indicating a pathological complete response. The histological diagnosis was reconsidered, and PACC was finally diagnosed via an additional immunohistological review. The patient has remained well with no recurrence for 6 years after surgery. This study is the first to report a case of pathological complete response with mFFX therapy for the recurrence of PACC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pancreatic NeoplasmsIrinotecanAntineoplastic Combined Chemotherapy ProtocolsOxaliplatinCarcinoma, Acinar CellFluorouracilLeucovorinLiver NeoplasmsNeoplasm Recurrence, LocalHumansMaleAdult

Stichwörter der Autor:innen

Modified FOLFIRINOX therapyPancreatic acinar cell carcinomaPathological complete response

Substanzen

IrinotecanfolfirinoxOxaliplatinFluorouracilLeucovorin

Autor:innen und Institutionen

  • Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, 3-1-1, Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan.
  • Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, 3-1-1, Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan. fujimori.nao.239@m.kyushu-u.ac.jp.
  • Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Department of Pathology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan.
  • Department of Anatomic Pathology, Graduate School of Medical Sciences, Kyushu University Hospital, Fukuoka, Japan.

Zitieren

APA

Teramatsu, K., Fujimori, N., Murakami, M., Yasumori, S., Matsumoto, K., Nakata, K., Nakamura, M., Koga, Y., Oda, Y., & Ogawa, Y. (2024). Pathological complete response with FOLFIRINOX therapy for recurrence of pancreatic acinar cell carcinoma. Clinical Journal of Gastroenterology. https://doi.org/10.1007/s12328-024-01983-2

Vancouver

Teramatsu K, Fujimori N, Murakami M, Yasumori S, Matsumoto K, Nakata K, et al. Pathological complete response with FOLFIRINOX therapy for recurrence of pancreatic acinar cell carcinoma. Clinical Journal of Gastroenterology. 2024. doi:10.1007/s12328-024-01983-2

BibTeX
@article{Teramatsu2024,
  author = {Teramatsu, Katsuhito and Fujimori, Nao and Murakami, Masatoshi and Yasumori, Sho and Matsumoto, Kazuhide and Nakata, Kohei and Nakamura, Masafumi and Koga, Yutaka and Oda, Yoshinao and Ogawa, Yoshihiro},
  title = {Pathological complete response with FOLFIRINOX therapy for recurrence of pancreatic acinar cell carcinoma},
  journal = {Clinical Journal of Gastroenterology},
  year = {2024},
  doi = {10.1007/s12328-024-01983-2}
}
Kostenlos starten →